Literature DB >> 1831127

Expression of different CD8 isoforms on distinct human lymphocyte subpopulations.

U Moebius1, G Kober, A L Griscelli, T Hercend, S C Meuer.   

Abstract

Human CD8+ lymphocyte subpopulations were analyzed for their expression of CD8 alpha and CD8 beta subunits. Investigations with uncloned peripheral blood lymphocytes as well as cloned human natural killer and T cell subpopulations demonstrate that CD3- natural killer cells, T cell receptor gamma/delta, and CD4+CD8+ T cell clones express exclusively CD8 alpha gene products. Structural analysis of CD8 molecules demonstrates that CD8 alpha+/beta- T lymphocytes surface express 75-kDa CD8 alpha/alpha homodimers whereas CD8 alpha/beta lymphocytes express concomittantly two CD8 isoforms of different molecular masses (67 kDa and 75 kDa, respectively). Peptide mapping of these latter two isoforms suggests that CD8 is expressed as alpha/alpha homodimers and alpha/beta heterodimers on CD8 alpha/beta+ cells. Importantly, we found that the two CD8 isoforms behave functionally different. Thus, in contrast to CD8 alpha/beta+/CD8 alpha/alpha+ T lymphocytes, cytolytic activity of CD8 alpha/beta-/CD8 alpha/alpha+ T cell clones was not inhibited by anti-CD8 monoclonal antibodies and the latter were not induced to proliferate following CD3/CD8 cross-linking.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831127     DOI: 10.1002/eji.1830210803

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  43 in total

1.  Familial CD8 deficiency due to a mutation in the CD8 alpha gene.

Authors:  O de la Calle-Martin; M Hernandez; J Ordi; N Casamitjana; J I Arostegui; I Caragol; M Ferrando; M Labrador; J L Rodriguez-Sanchez; T Espanol
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Prenatal ontogeny of lymphocyte subpopulations in pigs.

Authors:  M Sinkora; J Sinkora; Z Reháková; I Splíchal; H Yang; R M Parkhouse; I Trebichavsk
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 3.  The molecular determinants of CD8 co-receptor function.

Authors:  David K Cole; Bruno Laugel; Mathew Clement; David A Price; Linda Wooldridge; Andrew K Sewell
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

4.  T cells of the human intestinal lamina propria are high producers of interleukin-10.

Authors:  J Braunstein; L Qiao; F Autschbach; G Schürmann; S Meuer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

5.  Bop: a new T-cell-restricted gene located upstream of and opposite to mouse CD8b.

Authors:  I Hwang; P D Gottlieb
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  A new function for LAT and CD8 during CD8-mediated apoptosis that is independent of TCR signal transduction.

Authors:  Raedun L Clarke; Sandra Thiemann; Yosef Refaeli; Guy Werlen; Terry A Potter
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

7.  Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai.

Authors:  Weiming Jiang; Laiyi Kang; Hong-Zhou Lu; Xiaozhang Pan; Qingneng Lin; Qichao Pan; Yile Xue; Xinhua Weng; Yi-Wei Tang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.

Authors:  A M Verhagen; M R Brandon; A D Nash
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

10.  Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.

Authors:  M J Kuroda; J E Schmitz; W A Charini; C E Nickerson; C I Lord; M A Forman; N L Letvin
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.